Next meeting: Lisbon 2025 Registration

Wintermeeting 2024: Gavin Kenny

Patient-Maintained Sedation

Smart pharmacologic concepts beyond the OR

Gavin NC Kenny

Friday 19 January 11:00-11:30

Conscious sedation allows patients to undergo procedures which they would otherwise be unable to tolerate. The sedation must not contribute any morbidity or mortality to the procedure and ideally should be safe when used by surgeons and physicians as well as anaesthetists. Satisfactory sedation has been reported with TCI propofol in patients undergoing upper gastrointestinal endoscopy and surgery under regional blockade.

Patient-maintained sedation (PMS) allows the patient to control the target concentration of propofol using a button push. Studies suggest that this provides rapid, safe and effective relief of anxiety. The requirement was to develop a system which cannot allow the patient to overdose. Recent studies demonstrated the feasibility of using degradation in patient reaction time as a control function. The use of reaction time to control the target concentration of propofol may increase the margin of safety during sedation.

With more procedures being undertaken using minimally invasive surgical techniques, there will be increased requirements for conscious sedation. The techniques employed must be safe and efficacious and may be directed towards allowing the patient to participate more in the drug delivery. PMS propofol may fulfil this requirement.

Share the Post:

Related Posts

Wintermeeting 2024: Hernan Boveri

Lost in LOC. Titrating to effect. What does it reveal? Dr. Hernán Boveri, Italian Hospital of Buenos Aires, Argentina. Saturday 20 January 9:00-9:30 Currently, propofol is the most widely used intravenous anesthetic drug capable of providing safe general anesthesia. Propofol can be administered using different techniques including target-controlled infusion (TCI).One of the greatest strengths of TCI technology lies in its ability to maintain the pharmacological condition once the predefined clinical effect has been achieved. TCI models were developed based on

Read More

Wintermeeting 2024 : Stefan Schraag

The different models implemented in TCI:how it happend and who is responsible Stefan Schraag Saturday 10:30-11:00 Who safeguards PK models? It is a tricky task for most to develop a pharmacokinetic model. It gets even more difficult to publish one without any typos. And then, once you have achieved that, what to do with it and how? This is one of the questions surrounding the governance  of pharmacokinetic and pharmacodynamic research and scientific output when it informs medical device development

Read More

Join Our Newsletter

Please enable JavaScript in your browser to complete this form.
Scroll al inicio

This website collects cookies to deliver better user experience